Rotavirus causes severe diarrhea and dehydration in young infants but there have been fewer incidents of rotavirus since the FDA...
Rotavirus causes severe diarrhea and dehydration in young infants but there have been fewer incidents of rotavirus since the FDA approved the rotavirus vaccine. THEN - last month, the FDA became aware of the presence PCV1 in Rotarix and DNA from PCV1 and PCV2 in RotaTeq. RotaTeq and Rotarix are the two licensed vaccines for rotavirus in the United States. When this happened the use of Rotarix was suspended so the FDA could look into the issue. AS OF THIS WEEK - The U.S. Food and Drug Administration has revised its recommendations for both rotavirus vaccines. The FDA has determined that it is safe and appropriate for health care professionals to resume the use of Rotarix and to continue the use of RotaTeq. This means the FDA considers both vaccines safe for your little one. The FDA notes the following...
Both vaccines have a successful track record of safety and effectiveness and they have evaluated laboratory results from testing performed by the manufacturers and in its own laboratories. Based on a careful evaluation of these results, a thorough review of the scientific literature, and input from scientific and public health experts, FDA has no evidence that either PCV1 or PCV2 poses a safety risk. Neither PCV1 nor PCV2 is known to cause infection or illness in people. The benefits of the vaccines for infants are substantial, and include prevention of hospitalization for severe rotavirus disease in the U.S. The patient information for Rotarix and RotaTeq is posted on FDA’s web site.

Tags: rotavirus rotavirus vaccines rotavirus vaccines safe


recommended for you

Comments